Kaposi's sarcoma in Morocco: A pathological study with immunostaining for human herpesvirus-8 LNA-1

Pathology

Volumn 37, Issue 4, 2005, Pages 288-295

  Hbid, Oumkaltoum ^a,b   Belloul, Lamia ^c   Fajali, Noura ^d   Ismaili, Nadia ^c   Duprez, Renan ^a   Tanguy, Myriam ^a   Benomar, Hakima ^b   Tahri, El Hassane ^d,e   Gessain, Antoine ^a   Huerre, Michel ^a  

^a INSTITUT PASTEUR   (France)

^b Institut Pasteur du Maroc   (Morocco)

^c Avicenne Rabat   (Morocco)

^d IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^e FACULTÉ DES SCIENCES BEN M SIK   (Morocco)

Author keywords

HHV 8; Immunohistochemistry; Kaposi's sarcoma; LNA 1; Morocco; Pathology

Indexed keywords

ANTINUCLEAR ANTIBODY; LATENCY ASSOCIATED NUCLEAR ANTIGEN; TUMOR MARKER; VIRUS ANTIBODY;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; MALE; MOROCCO; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; SEROLOGY; VIRUS INFECTION;

EID: 23944493321     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020500169453     Document Type: Article

References (34)

1. Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med 2000; 342: 1027-38.
2. Dourmishev LA, Dourmishev AL, Palmeri D, Schwartz RA, Lukac DM. Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) epidemiology and pathogenesis. Microbiol Mol Biol Rev 2003; 67: 175-212.
3. Matondo P. Kaposi's sarcoma in Africa. Clin Dermatol 1999; 17: 197-207; discussion 105-6.
4. Besnard V, Euvrard S, Kanitakis J, et al. Kaposi's sarcoma after liver transplantation. Dermatology 1996; 193: 100-4.
5. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-9.
6. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 1995; 332: 1181-5.
7. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86: 1276-80.
8. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995; 332: 1186-91.
9. Dorfman RF. Kaposi's sarcoma revisited. Hum Pathol 1984; 15: 1013-7.
10. rd ed. St Louis: The CV Mosby Co, 1995; 658-69.
11. Rosai J. Ackerman's Surgical Pathology. 8th ed. St Louis: Mosby, 1996; 63-106.
12. Chan JK, Frizzera G, Fletcher CD, Rosai J. Primary vascular tumors of lymph nodes other than Kaposi's sarcoma. Analysis of 39 cases and delineation of two new entities. Am J Surg Pathol 1992; 16: 335-50.
13. Russell Jones R, Orchard G, Zeiger B, Wilson Jones E. Immunostaining for CD31 and CD34 in Kaposi sarcoma. J Clin Pathol 1995; 48: 1011-6.
14. Maiorana A, Luppi M, Barozzi P, Collina G, Fano RA, Torelli G. Detection of human herpès virus type 8 DNA sequence as a valuable aid in the differential diagnosis of Kaposi's sarcoma. Mod Pathol 1997; 10: 182-7.
15. Patel RM, Goldblum JR, Hsi ED. Immunohistochemical detection of human herpes virus-8 latent nuclear antigen-1 is useful in the diagnosis of Kaposi sarcoma. Mod Pathol 2004; 17: 456-60.
16. Hong A, Davies S, Lee CS. Immunohistochemical detection of the human herpes virus 8 (HHV8) latent nuclear antigen-1 in Kaposi's sarcoma. Pathology 2003; 35: 448-50.
17. Cheuk W, Wong KO, Wong CS, Dinkel JE, Ben-Dor D, Chan JK. Immunostaining for human herpesvirus 8 latent nuclear antigen-1 helps distinguish Kaposi sarcoma from its mimickers. Am J Clin Pathol 2004; 121: 335-42.
18. Ravisse P. Kaposi's sarcoma overseas (according to the Overseas Pasteur Institutes). (French.) Bull Soc Pathol Exot Filiales 1984; 77: 560-5.
19. Ben Tekaya N, Zeglaoui F, Ben Abdallah T, et al. Kaposi's sarcoma in Tunisia. Review of 91 cases. (French.) Tunis Med 2001; 79: 429-33.
20. Benslimane A, Essaket S, Zahni A, et al. Immunovirologic profile of Kaposi's sarcoma in Morocco. (French.) Presse Med 1987; 16: 917.
21. Chadli A, Rethers L, Landreat A, Habanec B. La physionomie du cancer en Tunisie. Etude de 7959 cancers primitifs. Arch Inst Pasteur de Tunis 1976; 4: 317-423.
22. Chakib A, Hliwa W, Marih L, Himmich H. Kaposi's sarcoma during HIV infection in Morocco (apropos of 50 cases). (French.) Bull Soc Pathol Exot 2004; 96: 86-9.
23. Kassimi BE, Benchemsi N, Mikou O, Ouazzani EE, Lakhdar H. Kaposi's sarcoma and anti-herpes virus 8 antibodies in Morocco. Médecine et Maladies Infectieuses 2003; 33: 226-8.
24. Krigel RL, Laubenstein LJ, Muggia FM. Kaposi's sarcoma: a new staging classification. Cancer Treat Rep 1983; 67: 531-4.
25. Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase techniques. Am J Clin Pathol 1981; 75: 816-2.
26. Plancoulaine S, Abel L, van Beveren M, Gessain A. High titers of anti-human herpesvirus 8 antibodies in elderly males in an endemic population. J Natl Cancer Inst 2002; 94: 1333-5.
27. Fouchard N, Lacoste V, Couppie P, et al. Detection and genetic polymorphism of human herpes virus type 8 in endemic or epidemic Kaposi's sarcoma from West and Central Africa, and South America. Int J Cancer 2000; 85: 166-70.
28. Hisaoka M, Hashimoto H, Iwamasa T. Diagnostic implication of Kaposi's sarcoma-associated herpesvirus with special reference to the distinction between spindle cell hemangioendothelioma and Kaposi's sarcoma. Arch Pathol Lab Med 1998; 122: 72-6.
29. Kaaya EE, Parravicini C, Ordonez C, et al. Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10: 295-305.
30. Weninger W, Partanen TA, Breiteneder-Geleff S, et al. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab Invest 1999; 79: 243-51.
31. Uccini S, Sirianni MC, Vincenzi L, et al. Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients. Am J Pathol 1997; 150: 929-38.
32. Di Bartolo D, Cesarman E. Uncovering the complexities of Kaposi's sarcoma through genome-wide expression analysis. Genome Biol 2004; 5: 247.
33. Hong YK, Foreman K, Shin JW, et al. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpes-virus. Nat Genet 2004; 36: 683-5.
34. Wang HW, Trotter MW, Lagos D, et al. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 2004; 36: 687-93.